Re: Farmas USA
Oral presentations from the public will be scheduled between approximately 1 p.m. to 2 p.m. on May 10, 2012. ( de 18,00 a 19,00 GMT)
Prometeo dixit.
Oral presentations from the public will be scheduled between approximately 1 p.m. to 2 p.m. on May 10, 2012. ( de 18,00 a 19,00 GMT)
Prometeo dixit.
Gracias Emilio.
Y como ves entrar y en caso de que haya noticias negativas vender al momento??
Ya que parece que sabremos la noticia dentro del horario de cotización creo que no seria mala idea. A mi lo que me da yuyu es que la noticia salga fuera de hora y abra al dia siguiente con un -20/30%
Gracias
Fijaos, ¡qué rectificación más curiosa! ¿Hay tema aquí?
-------------------------------------------------------------
CORRECTION: Arena Pharmaceuticals Awaits FDA Advisory Committee Meeting
LOS ANGELES, CALIFORNIA, May 07, 2012 (MARKETWIRE via COMTEX) -- Marketwire issued a news release earlier today on behalf of Arena Pharmaceuticals, Inc. (NASDAQ;ARNA) in error entitled, "Arena Pharmaceuticals Awaits FDA Advisory Committee Meeting". This release was issued without the approval of Arena Pharmaceuticals, Inc. Editors and other readers are advised to disregard this news release.
Marketwire regrets any inconvenience this may have caused.
Contacts:
Legitimate Market, Inc.
Market Research
250-448-1807
SOURCE: Arena Pharmaceuticals, Inc.
Copyright 2012 Marketwire, Inc., All rights reserved.
Más ARNA. Lo dejo para Jorge por si quiere traducirlo, que de opciones entiendo poco o nada, aunque intuyo que la gente se está posicionando en straddles para beneficiarse de la volatilidad futura de la acción. Es decir, esperan que o bien se dispare ARNA o bien se hunda en los abismos, al menos eso entiendo.
Saludos.
---------------------------
Options Players Wage on Arena Pharmaceuticals
Posted on 05/07/2012 by Jane Lacave
NEW YORK (AVAFIN) -- Arena Pharmaceuticals options contracts experienced a new 3-month record for both call and put contracts where a total of 42,955 call and 43,642 put contracts were traded in the busy trading session. The contract spread yielded a 1.02 put/call ratio.
The ratio skew implies that investors are hedging their positions in anticipation of a stock move. Today's unusual volume activity confirms that traders are re-balancing their portfolios.
ARNA is trading above the 50 day moving average and higher than the 200 day moving average. Shares of Arena Pharmaceuticals closed at $2.72, up $0.13 (+5.02%) in the last trading session. Today's volume of 13M shares is greater than the average volume of 9M shares.
Bueno...realmente lo que dice es que aun no hay nada aprovado por la FDA, pero eso ya lo sabiamos,no??
Saludos
Hola;
Sabeís en que pagina se podría buscar todas las pharmas que esperan productos pendientes por ser aprobadas por la FDA??
Saludos
ARNA
Premarket +10%